The GFI136N variant accelerates development of acute myeloid leukemia in acute myeloid leukemia/myelodysplastic syndrome mouse models.
•
GFI136N induces genomewide epigenetic changes in murine and human acute myeloid leukemia.
•
GFI36N human and murine leukemic cells respond specifically to histone acetyltransferase inhibitor treatment in vitro.
•
Use of histone acetyltransferase inhibitor prolongs survival of mice transplanted with GFI136N-expressing leukemia.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.